Last reviewed · How we verify
Seldane (TERFENADINE)
At a glance
| Generic name | TERFENADINE |
|---|---|
| Drug class | High Risk QT Prolonging Agents |
| Target | Histamine H1 receptor |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1985 |
Approved indications
- Allergic conjunctivitis
- Allergic rhinitis
- Chronic idiopathic urticaria
- Common cold
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
Common side effects
Drug interactions
- High Risk QT Prolonging Agents
- oleandomycin
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |